Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07085325 · ClinicalTrials.gov registry record
CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation
A clinical trial of Medulloblastoma, sponsored by St. Jude Children's Research Hospital.
- Recruiting
- Registry status
- 184
- Enrollment target
- 1
- Study location
NCT07085325 is a study of Medulloblastoma that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 184 participants, above the 135-participant average among 29 other Medulloblastoma trials with a reported enrollment target (36% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07085325, a study of Medulloblastoma, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.
- RECRUITING
- Registry status
- 184 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is being done to learn more about the long-term health and well-being of participants treated for medulloblastoma. The study is to decide which evaluations focusing on therapy-related lasting effects (or toxicities) should be considered. Medulloblastoma outcomes have improved with contemporary therapies including modern neurosurgical techniques and risk-adapted radiotherapy and chemotherapy regimens. However, survivors remain at risk for long-term health problems such as neurocognitive deficits, hearing loss, impaired cardiorespiratory fitness and physical performance, cardiac and neuroendocrine dysfunction, musculoskeletal conditions, and infertility.
Conditions Studied
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2026-03 |
| Est. Completion | 2031-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07085325
The ClinicalTrials.gov registry entry for NCT07085325 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 135-participant average among 29 other Medulloblastoma trials with a reported enrollment target (36% higher). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Medulloblastoma appearing as the primary indexed condition, and to 0 interventions.
NCT07085325 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT07085325 about?
NCT07085325 is a clinical study titled "CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation". The study is being done to learn more about the long-term health and well-being of participants treated for medulloblastoma. The study is to decide which evaluations focusing on therapy-related lasting effects (or toxicities) should be considered. Medulloblastoma outcomes have improved with contemp...
What is the current status of trial NCT07085325?
This trial is currently recruiting. The enrollment target is 184 participants. The study started on 2026-03. Estimated completion is 2031-10.
What conditions does trial NCT07085325 study?
This clinical trial studies the following conditions: Medulloblastoma.
Who is sponsoring clinical trial NCT07085325?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07085325 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Medulloblastoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
RECRUITING · Phase 2
-
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
RECRUITING · NA
-
Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
RECRUITING · Phase 1
-
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
RECRUITING · Phase 2
-
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
RECRUITING · Phase 4
-
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.